Cercar
01/01/2023
A Clinical-Genetic Risk Score for Predicting Cancer-Associated Venous Thromboembolism: A Development and Validation Study Involving Two Independent Prospective Cohorts
Muñoz A., Ay C., Grilz E., López S., Font C., Pachón V., Castellón V., Martínez-Marín V., Salgado M., Martínez E., Calzas J., Ortega L., Rupérez A., Salas E., Pabinger I., Soria J.M.. A Clinical-Genetic Risk Score for Predicting Cancer-Associated Venous Thromboembolism: A Development and Validation Study Involving Two Independent Prospective Cohorts. JOURNAL OF CLINICAL ONCOLOGY. 2023; 41(16)DOI:10.1200/JCO.22.00255. PMID:36730884. IF:42.100(Q1/1D).
01/01/2023
Results of haploidentical transplant in patients with donor-specific antibodies: a survey on behalf of the Spanish Group of Hematopoietic Transplant and Cell Therapy
Bailén R., Alenda R., Herruzo-Delgado B., Acosta-Fleitas C., Vallés A., Esquirol A., Fonseca M., Solán L., Sánchez-Vadillo I., Bautista G., Bento L., López-Godino O., Pérez-Martínez A., Torrent A., Zanabili J., Calbacho M., Moreno M.Á., Pascual-Cascón M.J., Guerra-Domínguez L., Chinea A., García-Cadenas I., López-Corral L., Boix-Giner F., López Lorenzo J.L., Humala K., Duarte R., Sampol A., Heras I., Vicario J.L., Balas A., Oarbeascoa G., Fernández-Caldas P., Anguita J., Kwon M.. Results of haploidentical transplant in patients with donor-specific antibodies: a survey on behalf of the Spanish Group of Hematopoietic Transplant and Cell Therapy. Frontiers in Immunology. 2023; 14DOI:10.3389/fimmu.2023.1165759. PMID:37304258. IF:5.700(Q1/3D).
01/01/2023
Monitoring of kinetics and exhaustion markers of circulating CAR-T cells as early predictive factors in patients with B-cell malignancies
García-Calderón C.B., Sierro-Martínez B., García-Guerrero E., Sanoja-Flores L., Muñoz-García R., Ruiz-Maldonado V., Jimenez-Leon M.R., Delgado-Serrano J., Molinos-Quintana Á., Guijarro-Albaladejo B., Carrasco-Brocal I., Lucena J.-M., García-Lozano J.-R., Blázquez-Goñi C., Reguera-Ortega J.L., González-Escribano M.-F., Reinoso-Segura M., Briones J., Pérez-Simón J.A., Caballero-Velázquez T.. Monitoring of kinetics and exhaustion markers of circulating CAR-T cells as early predictive factors in patients with B-cell malignancies. Frontiers in Immunology. 2023; 14DOI:10.3389/fimmu.2023.1152498. PMID:37122702. IF:5.700(Q1/3D).
01/12/2022
mRNA-1273 SARS-CoV-2 vaccine safety and COVID-19 risk perception in recently transplanted allogeneic hematopoietic stem cell transplant recipients (Nov, 10.1007/s00520-022-07376-w, 2022)
Albiol, N, Aso, O, Gomez-Perez, L, Triquell, M, Roch, N, Lazaro, E, Esquirol, A, Gonzalez, I, Lopez-Contreras, J, Sierra, J, Martino, R, Garcia-Cadenas, I. mRNA-1273 SARS-CoV-2 vaccine safety and COVID-19 risk perception in recently transplanted allogeneic hematopoietic stem cell transplant recipients (Nov, 10.1007/s00520-022-07376-w, 2022). SUPPORTIVE CARE IN CANCER. 2022; 30(12)DOI:10.1007/s00520-022-07452-1. PMID:36400980. IF:3.100(Q1/3D).
01/10/2022
Identification of Two Eosinophil Subsets in Induced Sputum from Patients with Allergic Asthma According to CD15 and CD66b Expression
Curto, E, Mateus-Medina, EF, Crespo-Lessmann, A, Osuna-Gomez, R, Ujaldon-Miro, C, Garcia-Moral, A, Galvan-Blasco, P, Soto-Retes, L, Ramos-Barbon, D, Plaza, V. Identification of Two Eosinophil Subsets in Induced Sputum from Patients with Allergic Asthma According to CD15 and CD66b Expression. International Journal of Environmental Research and Public Health. 2022; 19(20)DOI:10.3390/ijerph192013400. PMID:36293979. IF:4.614(Q1/3D).
01/10/2022
Characteristics of Graft-Versus-Host Disease (GvHD) After Post-Transplantation Cyclophosphamide Versus Conventional GvHD Prophylaxis
Saliba, RM, Alousi, AM, Pidala, J, Arora, M, Spellman, SR, Hemmer, MT, Wang, T, Abboud, C, Ahmed, S, Antin, JH, Beitinjaneh, A, Buchbinder, D, Byrne, M, Cahn, JY, Choe, H, Hanna, R, Hematti, P, Kamble, RT, Kitko, CL, Laughlin, M, Lekakis, L, MacMillan, ML, Martino, R, Mehta, PA, Nishihori, T, Patel, SS, Perales, MA, Rangarajan, HG, Ringden, O, Rosenthal, J, Savani, BN, Schultz, KR, Seo, S, Teshima, T, van der Poel, M, Verdonck, LF, Weisdorf, D, Wirk, B, Yared, JA, Schriber, J, Champlin, RE, Ciurea, SO. Characteristics of Graft-Versus-Host Disease (GvHD) After Post-Transplantation Cyclophosphamide Versus Conventional GvHD Prophylaxis. Transplantation And Cellular Therapy. 2022; 28(10)DOI:10.1016/j.jtct.2022.07.013. PMID:35853610. IF:3.200(Q2/5D).